SCHEMBL11411

SCHEMBL11411

CC(Cc1cc2cc(-c3ccco3)ccc2nc1N)C(=O)NCC1CCCOC1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.60
CTSD P07339 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11508 0.90 BACE1 (0.73) BACE1CTSD
SCHEMBL14321494 0.86 BACE1 (0.82) BACE1
SCHEMBL11458 0.84 BACE1 (0.65) BACE1CTSD
SCHEMBL14321154 0.84 BACE1 (0.65) BACE1CTSD
SCHEMBL11539 0.84 BACE1 (0.65) BACE1CTSD
SCHEMBL17620362 0.81 BACE1 (0.91) BACE1CTSD
SCHEMBL11963 0.78 BACE1 (0.70) BACE1CTSD
SCHEMBL11906 0.76 BACE1 (0.73) BACE1CTSD
SCHEMBL11772 0.76 BACE1 (0.52) BACE1CTSD
SCHEMBL11771 0.76 BACE1 (0.52) BACE1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2504315-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2012-10-03 EP claimed
WO-2011063233-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2011-05-26 WO claimed
EP-2504315-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2012-10-03 EP disclosed
WO-2011063233-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2011-05-26 WO disclosed